X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2995) 2995
Publication (195) 195
Book Review (22) 22
Magazine Article (13) 13
Book Chapter (2) 2
Paper (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2162) 2162
male (1952) 1952
atorvastatin calcium (1867) 1867
index medicus (1715) 1715
atorvastatin (1541) 1541
female (1523) 1523
middle aged (1286) 1286
pyrroles - administration & dosage (1153) 1153
heptanoic acids - administration & dosage (1152) 1152
statins (1084) 1084
aged (957) 957
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (953) 953
pyrroles - therapeutic use (756) 756
heptanoic acids - therapeutic use (755) 755
animals (745) 745
treatment outcome (696) 696
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (678) 678
cholesterol (663) 663
pharmacology & pharmacy (662) 662
adult (651) 651
cardiac & cardiovascular systems (615) 615
simvastatin (562) 562
anticholesteremic agents - administration & dosage (478) 478
heptanoic acids - pharmacology (476) 476
pyrroles - pharmacology (475) 475
cholesterol, ldl - blood (474) 474
dose-response relationship, drug (473) 473
rats (401) 401
risk factors (386) 386
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (383) 383
drug therapy, combination (374) 374
atherosclerosis (363) 363
lipids (362) 362
anticholesteremic agents - therapeutic use (345) 345
antilipemic agents (342) 342
hypercholesterolemia - drug therapy (329) 329
rosuvastatin (329) 329
research (323) 323
drug therapy (320) 320
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (315) 315
double-blind method (312) 312
pravastatin (312) 312
hypercholesterolemia (304) 304
rosuvastatin calcium (304) 304
risk (296) 296
prevention (294) 294
time factors (286) 286
heptanoic acids - adverse effects (285) 285
pyrroles - adverse effects (285) 285
dosage and administration (276) 276
inflammation (276) 276
care and treatment (275) 275
prospective studies (268) 268
medicine, general & internal (262) 262
abridged index medicus (260) 260
cardiovascular disease (255) 255
peripheral vascular disease (250) 250
therapy (250) 250
atorvastatin calcium - administration & dosage (248) 248
statin (247) 247
cholesterol - blood (244) 244
analysis (243) 243
cardiovascular (240) 240
disease (240) 240
follow-up studies (226) 226
cardiovascular diseases (219) 219
simvastatin - administration & dosage (218) 218
mice (217) 217
statin therapy (214) 214
c-reactive protein (211) 211
coronary-heart-disease (207) 207
lipids - blood (207) 207
oxidative stress (200) 200
drug administration schedule (196) 196
simvastatin - therapeutic use (195) 195
fluorobenzenes - administration & dosage (192) 192
aged, 80 and over (191) 191
drug interactions (188) 188
sulfonamides - administration & dosage (184) 184
health aspects (182) 182
pyrimidines - administration & dosage (181) 181
disease models, animal (180) 180
efficacy (178) 178
expression (178) 178
triglycerides - blood (178) 178
cardiovascular-disease (176) 176
myocardial-infarction (175) 175
anticholesteremic agents - pharmacology (171) 171
coronary heart disease (171) 171
cholesterol, hdl - blood (169) 169
safety (168) 168
rats, wistar (164) 164
hypercholesterolemia - blood (163) 163
studies (163) 163
cardiovascular diseases - prevention & control (162) 162
hyperlipidemias - drug therapy (162) 162
cardiology (161) 161
ezetimibe (160) 160
medicine (160) 160
cardiovascular agents (157) 157
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2841) 2841
German (40) 40
Russian (40) 40
Chinese (22) 22
Spanish (13) 13
French (12) 12
Hungarian (6) 6
Italian (6) 6
Japanese (6) 6
Ukrainian (5) 5
Polish (4) 4
Swedish (4) 4
Czech (3) 3
Danish (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2016, Volume 504, Issue 1-2, pp. 70 - 79
Journal Article
JAMA, ISSN 0098-7484, 03/2016, Volume 315, Issue 9, pp. 877 - 888
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2016, Volume 67, Issue 11, pp. 1278 - 1285
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 244, pp. 138 - 146
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2017, Volume 254, pp. 10 - 22
Atorvastatin calcium (ATV), a cholesterol-lowering agent, suffers from poor systemic availability (14%) after oral administration in addition to other side... 
Atorvastatin calcium | Transdermal delivery | Oxidative stress | Nanotransfersomes | Hyperlipidemia | Liver toxicity | LASER-SCANNING MICROSCOPY | DRUG-DELIVERY | ULTRADEFORMABLE LIPOSOMES | DEPENDENT PATHWAYS | CARRIERS | CHEMISTRY, MULTIDISCIPLINARY | EDGE ACTIVATORS | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | SKIN | IN-VIVO EVALUATION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Lecithins - metabolism | Polysorbates - chemistry | Rats, Wistar | Atorvastatin Calcium - administration & dosage | Biological Availability | Male | Polyethylene Glycols - chemistry | Administration, Cutaneous | Hydroxymethylglutaryl-CoA Reductase Inhibitors - chemistry | Nanocapsules - chemistry | Cholesterol - chemistry | Atorvastatin Calcium - toxicity | Lecithins - chemistry | Liver - drug effects | Esters - chemistry | Glycerol - analogs & derivatives | Glycerol - chemistry | Polyethylene Glycols - metabolism | Transdermal Patch | Glycerides - chemistry | Fatty Acids - chemistry | Hydroxymethylglutaryl-CoA Reductase Inhibitors - toxicity | Hyperlipidemias - drug therapy | Atorvastatin Calcium - chemistry | Skin Absorption | Permeability | Chemistry, Pharmaceutical | Particle Size | Animals | Poloxamer | Drug Liberation | Hyperlipidemias - chemically induced | Drug Delivery Systems - methods | Esters | Polyethylene glycol | Fatty acids | Liver | Transdermal medication | Membrane lipids | Enzymes | Low density lipoproteins
Journal Article
Thrombosis Research, ISSN 0049-3848, 2016, Volume 150, pp. 90 - 95
Abstract Background Statins represent a pivotal treatment in coronary artery disease, offering a reduction in cardiovascular risk even beyond their... 
Hematology, Oncology and Palliative Medicine | Platelet aggregation | Vitamin D | Coronary artery disease | Statins | RANDOMIZED-TRIALS | CARDIOVASCULAR EVENTS | D DEFICIENCY | RISK | ISCHEMIC-HEART-DISEASE | ATORVASTATIN | DENSITY-LIPOPROTEIN CHOLESTEROL | ANGIOPLASTY | THERAPY | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ELEVATION MYOCARDIAL-INFARCTION | Blood Platelets - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Rosuvastatin Calcium - therapeutic use | Atorvastatin Calcium - pharmacology | Atorvastatin Calcium - administration & dosage | Humans | Middle Aged | Male | Simvastatin - pharmacology | Coronary Artery Disease - blood | Rosuvastatin Calcium - administration & dosage | Dose-Response Relationship, Drug | Platelet Aggregation Inhibitors - administration & dosage | Coronary Artery Disease - pathology | Platelet Aggregation Inhibitors - pharmacology | Female | Platelet Aggregation - drug effects | Blood Platelets - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Atorvastatin Calcium - therapeutic use | Simvastatin - administration & dosage | Rosuvastatin Calcium - pharmacology | Coronary Artery Disease - drug therapy | Vitamin D - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Aged | Care and treatment | Cardiac patients | Calcifediol | Dosage and administration | Alfacalcidol | Coronary heart disease | Cardiovascular agents | Hypercholesterolemia | Thrombin | Cardiology
Journal Article
Journal Article
Journal Article
Life Sciences, ISSN 0024-3205, 06/2018, Volume 203, pp. 129 - 140
Journal Article